After finishing at $13.36 in the prior trading day, Cerence Inc (NASDAQ: CRNC) closed at $12.11, down -9.36%. On the day, 560062 shares were traded.
Ratios:
Our goal is to gain a better understanding of CRNC by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.65 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 275.75. For the most recent quarter (mrq), Quick Ratio is recorded 1.86 and its Current Ratio is at 1.86. In the meantime, Its Debt-to-Equity ratio is 0.40 whereas as Long-Term Debt/Eq ratio is at 0.39.
On February 09, 2023, Craig Hallum Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $24 to $40.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 01 ’24 when BEAUDOIN THOMAS L sold 5,000 shares for $15.35 per share. The transaction valued at 76,744 led to the insider holds 252,921 shares of the business.
Ortmanns Stefan sold 15,389 shares of CRNC for $228,043 on Mar 22 ’24. The Chief Executive Officer now owns 537,150 shares after completing the transaction at $14.82 per share. On Mar 21 ’24, another insider, BEAUDOIN THOMAS L, who serves as the Director of the company, sold 5,000 shares for $14.99 each. As a result, the insider received 74,926 and left with 257,921 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.45 while its Price-to-Book (P/B) ratio in mrq is 0.68.
Stock Price History:
Over the past 52 weeks, CRNC has reached a high of $36.79, while it has fallen to a 52-week low of $12.99.
Shares Statistics:
A total of 40.42M shares are outstanding, with a floating share count of 35.86M. Insiders hold about 13.94% of the company’s shares, while institutions hold 92.30% stake in the company.
Earnings Estimates
Its stock is currently analyzed by Centene Corporation different market analysts. The consensus estimate for the next quarter is $12.11, with high estimates of $24.56 and low estimates of $2.77.
